Aloxi GMP Problems May Trigger Import Controls
This article was originally published in The Pink Sheet Daily
Executive Summary
France's Pierre Fabre Medicament Production could find the antiemetic it manufactures for Eisai is barred from the U.S. until it takes corrective action on manufacturing problems.